Proteostasis Therapeutics (PTI) Stock: Up On Orphan Drug Designation

Proteostasis Therapeutics PTI Stock News

Proteostasis Therapeutics Inc (NASDAQ: PTI) is grabbing the attention of investors with premarket gains of more than 20%. The gains come after the company made an announcement with regard to the receipt of orphan drug designation. PTI Receives Orphan Drug Designation In Europe The news broke via press release early this morning. In the release, … Read more

Biotech News 2/16/15 to 2/20/15

Oncolytics Biotech (ONCY) Shares of Oncolytics gained about 36% on 2/17/15 when it had announced that the company received FDA Orphan Drug Designation status for its pancreatic cancer drug Reolysin. Reolysin is a variant of the ReoVirus which occurs naturally in the environment. Oncolytics has engineered Reolysin to multiply at an alarming rate inside of … Read more